[Prognostic significance of alterations in telomeric repeat length in patients with pathological stage I-II non-small cell lung cancer]

MLA

T, Hirashima, et al. “[Prognostic Significance of Alterations in Telomeric Repeat Length in Patients with Pathological Stage I-II Non-Small Cell Lung Cancer].” Nihon Rinsho. Japanese Journal of Clinical Medicine, vol. 56, no. 5, June 1998. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c0388b86386b24aeefb111a2b01e1b80&authtype=sso&custid=ns315887.

APA

T, H., T, K., T, N., M, K., & I, K. (1998). [Prognostic significance of alterations in telomeric repeat length in patients with pathological stage I-II non-small cell lung cancer]. Nihon Rinsho. Japanese Journal of Clinical Medicine, 56(5).

Chicago

T, Hirashima, Komiya T, Nitta T, Kobayashi M, and Kawase I. 1998. “[Prognostic Significance of Alterations in Telomeric Repeat Length in Patients with Pathological Stage I-II Non-Small Cell Lung Cancer].” Nihon Rinsho. Japanese Journal of Clinical Medicine 56 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c0388b86386b24aeefb111a2b01e1b80&authtype=sso&custid=ns315887.